Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Circulating Tumor Cells

Circulating Tumor Cells

Date: Thursday, 2 February 2012 - Friday, 3 February 2012
Location: San Diego, USA


Keynote Speakers

Stefanie Jeffrey

Stefanie Jeffrey
Chief, Stanford University School of Medicine

Brian Kirby

Brian Kirby
Associate Professor, Cornell University

Katharina Pachmann

Katharina Pachmann
Professor, University of Jena

Overview

Our inaugural Circulating Tumour Cells 2012 conference is expanding on the interest expressed in the CTC sessions of our very popular Single Cell Analysis conferences.

With oncologists increasingly using CTCs to gather prognostic information on their patients, it is more and more apparent that CTCs can offer clinicians a non-invasive means of sampling for genetic markers, monitoring treatment responsiveness, aiding in treatment decision-making and indicating novel drug targets.
However, there are still issues and questions being raised about the clinical significance of CTCs, as well as the need to improve sensitivity, reproducibility and reliability of their use in disease monitoring. To solve these problems there is a real need for increased collaboration and understanding if the industry is to effectively use CTCs to improve cancer survival rates and provide significant cost-savings.

The Circulating Tumor Cells 2012 conference and exhibition offers delegates 2 days of world class speakers who are at the forefront of the field and whose talks will be exploring, as well as attempting to answer, some of these CTC questions.

Running alongside the conference will be an exhibition covering the latest technological advances and associated services within these fields.

Agenda Topics

  • CTCs as Prognostic or Predictive Biomarkers for Cancer
  • Early Cancer Detection
  • EMT in Cell Generation and Survival
  • Isolation and Analysis of CTCs: Emerging Technologies Impacting the Field
  • Methods of Enumeration of CTCs as a Predictor
  • Significance of CTCs in Various Types of Cancer: Liquid Tumors vs. Solid Tumors
  • The use of Circulating Tumor Cells in Clinical Development
  • Understanding the Role of EMT in Metastasis

Sponsorship and Exhibition Opportunities

Exhibition Team,
exhibitors@selectbio.com
+44 (0) 1206 501654

Confirmed Speakers to date

Catherine Alix-Panabieres, Associate Professor, University Medical Center of Montpellier
Daniel Boffa, Assistant Professor, Yale School of Medicine
Jeffrey Chalmers, Professor, Ohio State University
Wolfgang Janni, Head, University of Dusseldorf
Powrnima Joshi, Research Fellow, Lerner Research Institute/Cleveland Clinic Foundation
Michael King, Associate Professor, Cornell University
Peter Kuhn, Professor, Scripps Research Institute
Minetta Liu, Associate Professor and Chair, Oncology Research, Mayo Clinic
Natalia Malara, , University of Catanzaro
Marek Malecki, President, Phoenix Biomolecular Engineering Foundation
Dario Marchetti, Endowed Professor, Baylor College of Medicine
James Reuben, Professor, The University of Texas MD Anderson Cancer Center
Gavin Robertson, Professor, Penn State Melanoma Center
Denis Smirnov, Associate Director, On Q Ity
Lihua Wang, Senior Scientist, Frederick National Laboratory for Cancer Research
John Zhang, Associate Professor, The University Of Texas at Austin


Exhibition Sponsors Media Sponsors Official Journal Partner Networking
Drug Discovery WoMetaTagsrld U-Networks

Add to Calendar ▼2012-02-02 00:00:002012-02-03 00:00:00Europe/LondonCirculating Tumor CellsCirculating Tumor Cells in San Diego, USASan Diego, USASELECTBIOenquiries@selectbiosciences.com